[2-(4-Morpholin-4-yl-1h-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]amine

Catalog No.: 
ACPIBU422
CAS No.: 
1105196-39-1
Molecular Formula: 
C11H16N6O
Molecular Weight: 
248.29
[2-(4-Morpholin-4-yl-1h-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$132.00InquiryInquiry
1g95%$408.00InquiryInquiry
5g95%$1185.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[2-(4-Morpholin-4-yl-1h-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]amine
IUPAC Name2-(4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethan-1-amine
MDL No.MFCD11986542
Molecular FormulaC11H16N6O
Molecular Weight248.29
SMILESNCCN1N=CC2=C(N3CCOCC3)N=CN=C21
InChI KeyGVSWYHWDRJZNQN-UHFFFAOYSA-N
Synonym[2-(4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]amine;2-(4-Morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl)-ethylamine;1H-Pyrazolo[3,4-d]pyrimidine-1-ethanamine, 4-(4-morpholinyl)-
CAS No.1105196-39-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPIBU422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPIBU422 route product structure diagram
    ACPIBU4221105196-39-1
Inquiry

2. ACPIBU422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPIBU422 route product structure diagram
    ACPIBU4221105196-39-1
Inquiry

3. ACPIBU422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPIBU422 route product structure diagram
    ACPIBU4221105196-39-1
Inquiry

Comments (0)